Plain-English translation of NCT05871164 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is following patients who receive a specialized procedure called ultrasound-guided radiofrequency to treat pancreatic tumors. The procedure uses a thin needle guided by ultrasound imaging to deliver heat directly to the tumor. Researchers want to understand how well this treatment works over five years and how safe it is for patients.
Pancreatic cancer is difficult to treat, and doctors need better ways to destroy tumors while keeping patients safe. This study aims to learn whether this heat-based needle treatment can be an effective option for people with pancreatic tumors.
You likely qualify if…
You likely don't qualify if…
You would receive the radiofrequency needle treatment as planned by your care team. After treatment, you would have follow-up visits at 15 days, 6 months, 12 months, and then yearly for up to five years. These visits are part of your normal care and will track how well the treatment is working and how you are doing.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
France
Collaborators
Euraxi Pharma
Enrollment target
~200 participants
Started
June 2023
Primary completion
May 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Bertrand NAPOLEON, MD
GCS Ramsay Santé pour l'Enseignement et la Recherche
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.